BioSpace News Archive

Press Releases

ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer’s Trial

July 26, 2024
·
8 min read
Press Releases

ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders

July 26, 2024
·
6 min read
Press Releases

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

July 26, 2024
·
1 min read
Press Releases

Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024

July 26, 2024
·
3 min read
Press Releases

Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine

July 26, 2024
·
4 min read
Press Releases

U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata

July 26, 2024
·
11 min read
Press Releases

Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

July 26, 2024
·
2 min read
Press Releases

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

July 26, 2024
·
14 min read
Press Releases

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

July 26, 2024
·
5 min read
Press Releases

OneMedNet Announces $4.6 Million Private Placement

July 26, 2024
·
5 min read